Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
October 29, 2026 0.4122
October 28, 2026 0.4403
October 27, 2026 0.4192
October 26, 2026 0.4262
October 23, 2026 0.5671
October 22, 2026 0.7961
October 21, 2026 0.8102
October 20, 2026 0.8102
October 19, 2026 0.7715
October 16, 2026 0.7644
October 15, 2026 0.8243
October 14, 2026 0.7891
October 13, 2026 0.7996
October 12, 2026 0.8877
October 09, 2026 0.937
October 08, 2026 0.9546
October 07, 2026 0.8666
October 06, 2026 0.8313
October 05, 2026 0.9053
October 02, 2026 0.9723
October 01, 2026 0.9582
September 30, 2026 0.9687
September 29, 2026 0.9229
September 28, 2026 0.8807
September 25, 2026 0.8877
Date Value
September 24, 2026 0.8807
September 23, 2026 0.9229
September 22, 2026 1.043
September 21, 2026 1.046
September 18, 2026 1.014
September 17, 2026 1.014
September 16, 2026 0.9511
September 15, 2026 0.9617
September 14, 2026 1.029
September 11, 2026 0.9899
September 10, 2026 0.9758
September 09, 2026 1.053
September 08, 2026 1.099
September 04, 2026 1.103
September 03, 2026 1.099
September 02, 2026 1.092
September 01, 2026 1.092
August 31, 2026 1.113
August 28, 2026 1.096
August 27, 2026 1.120
August 26, 2026 1.113
August 25, 2026 1.159
August 24, 2026 1.124
August 21, 2026 1.162
August 20, 2026 1.131

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Anika Therapeutics, Inc. 2.124
MiMedx Group, Inc. 2.745
ABVC BioPharma, Inc. 2.605
Enovis Corp. 0.8905
Edwards Lifesciences Corp. 5.128

Price to Book Value Related Metrics

PS Ratio 266.67
PEG Ratio -2.118
Price 1.17
Earnings Yield -113.6%
Market Cap 133.48M
PEGY Ratio -2.118